The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Why would a patient trust a peptide more than a statin? STAT FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC BPC 157 AH Clinics The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics